Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Access Midstream Partners LP (ACMP)

Page 1 of 2

Is Access Midstream Partners LP (NYSE:ACMP) a great investment today? The smart money is getting more optimistic. The number of bullish hedge fund bets increased by 2 lately.

Access Midstream logo

At the moment, there are dozens of gauges market participants can use to track Mr. Market. A duo of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite money managers can outclass the broader indices by a healthy amount (see just how much).

Equally as key, optimistic insider trading sentiment is a second way to break down the financial markets. As the old adage goes: there are a variety of incentives for an executive to cut shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Plenty of academic studies have demonstrated the useful potential of this method if you know what to do (learn more here).

With all of this in mind, we’re going to take a gander at the recent action regarding Access Midstream Partners LP (NYSE:ACMP).

What have hedge funds been doing with Access Midstream Partners LP (NYSE:ACMP)?

At Q1’s end, a total of 7 of the hedge funds we track held long positions in this stock, a change of 40% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes meaningfully.

Of the funds we track, Balyasny Asset Management, managed by Dmitry Balyasny, holds the largest position in Access Midstream Partners LP (NYSE:ACMP). Balyasny Asset Management has a $33.3 million position in the stock, comprising 0.5% of its 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $14.9 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Some other hedge funds that hold long positions include Richard Driehaus’s Driehaus Capital, Andrew R. Midler’s Savitr Capital and Ken Griffin’s Citadel Investment Group.

As industrywide interest jumped, some big names were breaking ground themselves. Driehaus Capital, managed by Richard Driehaus, created the biggest position in Access Midstream Partners LP (NYSE:ACMP). Driehaus Capital had 11.1 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also initiated a $1.1 million position during the quarter.

What do corporate executives and insiders think about Access Midstream Partners LP (NYSE:ACMP)?

Insider purchases made by high-level executives is at its handiest when the company in question has seen transactions within the past six months. Over the last half-year time frame, Access Midstream Partners LP (NYSE:ACMP) has experienced 3 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Access Midstream Partners LP (NYSE:ACMP). These stocks are InterOil Corporation (USA) (NYSE:IOC), Murphy Oil Corporation (NYSE:MUR), HollyFrontier Corp (NYSE:HFC), CVR Energy, Inc. (NYSE:CVI), and Tesoro Corporation (NYSE:TSO). This group of stocks belong to the oil & gas refining & marketing industry and their market caps resemble ACMP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!